Literature DB >> 27465420

Intracranial Inflammatory Myofibroblastic Tumor with Sarcomatous Local Recurrence.

Yoen-Young Chuah1, Tsewang Tashi2, Cherng-Gueih Shy3, Jean-Shiunn Shyu4, Ming-Jeng Dong5, Er-Jung Hsueh6.   

Abstract

CASE DESCRIPTION: A 20-year-old woman presented with a rare intracranial inflammatory myofibroblastic tumor (IMT) manifesting as headache and insomnia. Magnetic resonance imaging showed a tumorous lesion with heterogeneous enhancement at the right temporal lobe, as well as perifocal edema with midline shift. The tumor was totally resected with the margin free. Pathologic examination showed IMT with myofibroblastic cells admixed with collagen fibers. Sarcomatous change in morphology was observed in tumor recurrence within 7 months.
CONCLUSIONS: Surgical resection and whole brain radiation are recommended in patients with IMT.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaplastic lymphoma kinase; Brain; Inflammatory myofibroblastic tumor; Recurrence; Sarcomatous change

Mesh：

Year:  2016        PMID： 27465420     DOI： 10.1016/j.wneu.2016.07.060

Source DB:  PubMed          Journal:  World Neurosurg        ISSN： 1878-8750            Impact factor:   2.104


  2 in total

1.  Genetic Testing and Immunotherapy for Intracranial Inflammatory Myofibroblastic Tumor: A Case Report.

Authors:  Xiangji Meng; Lei Zhang; Qi Wang; Jimin Chen; Chunmei Zhang; Rongjie Tao; Yong Wang
Journal:  Onco Targets Ther       Date:  2022-04-01       Impact factor: 4.147

2.  Treatment, pathological characteristics, and prognosis of pulmonary inflammatory myofibroblastic tumor-a retrospective study of 8 cases.

Authors:  Xiao Zhu; Wen-Bang Chen; Fu-Bao Xing; Shao Zhou; Zhen Tang; Xiao-Jun Li; Lei Zhang; Yu-Chen Huang
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.